Article Versions Notes

Keil M, Conrad T, Becker M, Keilholz U, Yaspo M-L, Lehrach H, Schütte M, Haybaeck J, Hoffmann J. Modeling of Personalized Treatments in Colon Cancer Based on Preclinical Genomic and Drug Sensitivity Data. Cancers. 2021; 13(23):6018. https://doi.org/10.3390/cancers13236018

Keil, Marlen, Theresia Conrad, Michael Becker, Ulrich Keilholz, Marie-Laure Yaspo, Hans Lehrach, Moritz Schütte, Johannes Haybaeck, and Jens Hoffmann. 2021. "Modeling of Personalized Treatments in Colon Cancer Based on Preclinical Genomic and Drug Sensitivity Data" Cancers 13, no. 23: 6018. https://doi.org/10.3390/cancers13236018

Keil, M., Conrad, T., Becker, M., Keilholz, U., Yaspo, M.-L., Lehrach, H., Schütte, M., Haybaeck, J., & Hoffmann, J. (2021). Modeling of Personalized Treatments in Colon Cancer Based on Preclinical Genomic and Drug Sensitivity Data. Cancers, 13(23), 6018. https://doi.org/10.3390/cancers13236018